Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Kintor was founded by Chinese academic researchers returning from overseas. It has two main drugs, proxalutamide which targets prostate cancer and breast cancer, and pyrilutamide which targets androgenic alopecia. The most advanced drug candidate, proxalutamide, entered into Phase III clinical trial and the NDA for mCRPC indication could be submitted as early as 2020 based on interim results. Having said that the clinical trial for TNBC is still in the early stage of development. Pyrilutamide ...
Kintor was founded by Chinese academic researchers returning from overseas. It has two main drugs, proxalutamide which targets prostate cancer and breast cancer, and pyrilutamide which targets androgenic alopecia. The most advanced drug candidate, proxalutamide, entered into Phase III clinical trial and the NDA for mCRPC indication could be submitted as early as 2020 based on interim results. Having said that the clinical trial for TNBC is still in the early stage of development. Pyrilutamid...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.